Almirall receives A- rating by CDP for its contributions to the fight against climate change
- This is the second consecutive year that Almirall gets a “A-” recognition from the CDP (Carbon Disclosure Project) for its transparency and management of its carbon footprint and impact on climate change
- Almirall recently validated its carbon reduction targets to achieve net zero greenhouse gas (GHG) emissions across the value chain by 2050
Photovoltaic panels at Almirall's headquarters in Barcelona
BARCELONA, Spain. February 12th, 2024 – Almirall S.A. (BME: ALM), a global pharmaceutical company dedicated to medical dermatology, announced the recognition by CDP for its transparency and management of its carbon footprint related to the fight against climate change. Almirall achieved an excellent score of "A-, Leadership" in Climate Change for the second consecutive year, and a score of "B, Management" in Water Security, category in which the company has participated for the first time.
This recognition is the result of Almirall’s commitment to address climate change through actions focused on protecting the planet and promoting emission reduction initiatives throughout the entire value chain.
Since 2014, the company's commitment to environmental stewardship has been reflected through its increasing scores in the CDP assessment, with its recognition with the A- for Leadership since 2022.
CDP, a not-for-profit charity, has the goal to guide companies and governments to reduce their greenhouse gas emissions, safeguard water resources and protect forests. It independently evaluates data regarding environmental impact, risks and opportunities and is recognized as gold standard of environmental reporting with the most comprehensive dataset on corporate and city action.
“Achieving this recognition for our contributions to climate change is testament to our strong commitment to environmental protection and sustainability throughout our operations and value chain. As a healthcare company with a long-term view of our impact on people and societies, our contributions to creating a more sustainable future are at the heart of our business plan and actions,” commented Carlos Gallardo, Almirall’s CEO.
Moving towards the goal of net zero greenhouse gas emissions
The Science-Based Targets initiative (SBTi) validated in 2023 Almirall's targets to achieve net zero greenhouse gas (GHG) emissions across the value chain by 2050, under the "Net-Zero Standard". This means an effective reduction of 50% of its absolute GHG emissions from own sources and purchased electricity and indirect emissions produced in the value chain by 28% by 2030 compared to 2019.
Almirall's total electricity consumption already originates 100% from renewable sources. Through its Net Zero Strategy, Almirall plans to continue expanding its photovoltaic park until 2030 by installing new photovoltaic plants, expanding existing ones and concluding new PPAs (Power Purchase Agreements) to ensure this renewable electricity supply in the short and medium term. In addition, Almirall will also work to reduce emissions from its vehicle fleet by more than 50% by 2030. Almirall is also working to decarbonize the impact of the value chain by progressing in its Net Zero Supplier Engagement Programme that will be key to fulfil the commitments towards a net-zero 2050.
About Almirall
Almirall is a global pharmaceutical company dedicated to medical dermatology. We closely collaborate with leading scientists, healthcare professionals, and patients to deliver our purpose: to transform the patients' world by helping them realize their hopes and dreams for a healthy life. We are at the forefront of science to deliver ground-breaking, differentiated medical dermatology innovations that address patients´ needs.
Almirall, founded in 1944 and headquartered in Barcelona, is publicly traded on the Spanish Stock Exchange (ticker: ALM). Almirall (total revenue in 2022: €878.5 MM, 1800 employees globally) has a direct presence in 21 countries and affiliates in over 70 others.
For more information, please visit almirall.com
